VENKER ERIC (President & COO) sold 10.8% of their position (200K shares) of ROIVANT SCIENCES LTD. on the open market
Open‑market sale worth $4.38M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/14/2026ACC: 0001140361-26-001239
Officer· President & COO
Since Oct 2021
-200K
Net shares
Net seller
$4.38M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
200K acquired · 400K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+200K
Price / share
$3.85
Trade value
$770K
% of position
12.1%
1/12/2026
1.65M→1.85M
Common Shares
Direct
Shares
−200K
Price / share
$21.92
Trade value
$4.38M
% of position
10.8%
1/12/2026
1.85M→1.65M
Total
Net shares
+0.00
Net value
-$3.61M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 1/12/2026 | M · Option Exercise | +200K | $3.85 | $770K | 12.1% | 1.65M | 1.85M |
| Common Shares Direct | 1/12/2026 | S · Sale | −200K | $21.92 | $4.38M | 10.8% | 1.85M | 1.65M |
| Total | +0.00 | -$3.61M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
200K shares
Shares
−200K
Strike price
3.85
Held after
5.24M
Exercisable
—
1/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock200K shares | 1/12/2026 | M · Option Exercise | −200K | 3.85 | — | 5.24M |